David A Hyman
Biographic Data
| ID | 6417608 |
|---|---|
| NAME | David A Hyman |
| GIVEN NAMES | David A |
| FAMILY NAME | Hyman |
| SIGNATURE | HYMAN D A |
| AFFILIATIONS | Georgetown University |
| VERIFIED | No |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1990 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Crime, Punishment, and Expectations
Crime doesn't pay. Or does it? We study the role of expectations regarding sanctions and the likelihood of detection on whether people obey the law. We examine how expectations influence whether people obey the law and conduct simulations of various enforcement counterfactuals. We find the average assessment of the likelihood of detection is reasonably accurate, but those who (mistakenly) believe the probability is lower than it is are much more …
Third-Party litigation funding
Third-party litigation funding (“TPLF”) is controversial. To its detractors, TPLF creates serious ethical and national security risks, and results in defendants paying out large “blackmail settlements” based on marginal (if not wholly frivolous) claims. To its supporters, TPLF helps ensure access to justice by putting plaintiffs and their lawyers on a more equal footing with well-resourced defendants, and the willingness of sophisticated third pa…
Will Cash Price Transparency Benefit Patients
This Viewpoint discusses the ways in which cash price transparency might influence patients’ choice of clinician and how this would affect health care costs
Association of Past and Future Paid Medical Malpractice Claims
In this study of paid medical malpractice claims for all US physicians, a single prior paid claim was associated with substantial, long-lived higher future claim risk, independent of whether a physician was practicing in a high- or low-risk specialty, or whether a state publicly disclosed paid claims. Timely, noncoercive intervention, including education, has the potential to reduce future claims
Pharmacy Benefit Managers
Pharmacy benefit managers are intermediaries in the pharmaceutical supply chain and perform multiple roles in the management and distribution of pharmaceuticals to patients. When regulating PBMs, it is important to adopt policies that address market failure problems by improving PBM competition as opposed to policies designed to serve the narrow financial interests of other market participants (eg, pharmacies, pharmaceutical manufacturers) withou…
Epstein on Health Law and Policy
Richard Epstein is not known for his work on health law and policy. But in over 50 years in academics, he has written two books, 63 articles and book chapters, and a staggering number of op-eds and blog postings on a diverse array of health law and policy topics, ranging from medical malpractice and pharmaceuticals to obesity, organ sales, patient dumping, and privacy. This article focuses on Epstein’s contribution to three areas of health law an…
The Impact of Medical Malpractice Reforms
This article evaluates the effects of medical malpractice reform on claiming, malpractice premiums, physician supply, and defensive medicine. We conclude that damage caps materially reduce claim frequency, payouts per claim, and total payouts. The effects of damage caps on malpractice premiums, physician supply, and defensive medicine are more modest. It is difficult to quantify the impact of reforms other than damage caps—partly because reforms …
Government Organization/Reorganization
Vested Interests
Case Studies
In this case study, a general practitioner is offered the chance to invest in a free-standing radiology center. His return will be calculated based on the amount of his investment, not on his volume of referrals. The physician is concerned about the legal and ethical aspects of the arrangement . Berenson, a physician, comments that the proposed deal is "wholesome" compared to other kinds of economic practices in health care, and does not involve …
No prominent works on this page.
Case Studies
In this case study, a general practitioner is offered the chance to invest in a free-standing radiology center. His return will be calculated based on the amount of his investment, not on his volume of referrals. The physician is concerned about the legal and ethical aspects of the arrangement . Berenson, a physician, comments that the proposed deal is "wholesome" compared to other kinds of economic practices in health care, and does not involve …
Vested Interests
Government Organization/Reorganization
The Impact of Medical Malpractice Reforms
This article evaluates the effects of medical malpractice reform on claiming, malpractice premiums, physician supply, and defensive medicine. We conclude that damage caps materially reduce claim frequency, payouts per claim, and total payouts. The effects of damage caps on malpractice premiums, physician supply, and defensive medicine are more modest. It is difficult to quantify the impact of reforms other than damage caps—partly because reforms …
Epstein on Health Law and Policy
Richard Epstein is not known for his work on health law and policy. But in over 50 years in academics, he has written two books, 63 articles and book chapters, and a staggering number of op-eds and blog postings on a diverse array of health law and policy topics, ranging from medical malpractice and pharmaceuticals to obesity, organ sales, patient dumping, and privacy. This article focuses on Epstein’s contribution to three areas of health law an…
Association of Past and Future Paid Medical Malpractice Claims
In this study of paid medical malpractice claims for all US physicians, a single prior paid claim was associated with substantial, long-lived higher future claim risk, independent of whether a physician was practicing in a high- or low-risk specialty, or whether a state publicly disclosed paid claims. Timely, noncoercive intervention, including education, has the potential to reduce future claims
Pharmacy Benefit Managers
Pharmacy benefit managers are intermediaries in the pharmaceutical supply chain and perform multiple roles in the management and distribution of pharmaceuticals to patients. When regulating PBMs, it is important to adopt policies that address market failure problems by improving PBM competition as opposed to policies designed to serve the narrow financial interests of other market participants (eg, pharmacies, pharmaceutical manufacturers) withou…
Third-Party litigation funding
Third-party litigation funding (“TPLF”) is controversial. To its detractors, TPLF creates serious ethical and national security risks, and results in defendants paying out large “blackmail settlements” based on marginal (if not wholly frivolous) claims. To its supporters, TPLF helps ensure access to justice by putting plaintiffs and their lawyers on a more equal footing with well-resourced defendants, and the willingness of sophisticated third pa…
Will Cash Price Transparency Benefit Patients
This Viewpoint discusses the ways in which cash price transparency might influence patients’ choice of clinician and how this would affect health care costs
Crime, Punishment, and Expectations
Crime doesn't pay. Or does it? We study the role of expectations regarding sanctions and the likelihood of detection on whether people obey the law. We examine how expectations influence whether people obey the law and conduct simulations of various enforcement counterfactuals. We find the average assessment of the likelihood of detection is reasonably accurate, but those who (mistakenly) believe the probability is lower than it is are much more …
Business (7 works) · Political science (7 works) · Medicine (5 works) · Healthcare Policy and Management (4 works) · Law (4 works) · Economics (3 works) · Health care (3 works) · Healthcare cost, quality, practices (3 works) · Malpractice (3 works) · Medical Malpractice and Liability Issues (3 works)